ConcertAI Introduces TeraRecon AV™*, Advancing AI-Powered Medical Imaging with New Structural Heart and SaaS Capabilities

• TeraRecon AV^TM delivers advanced imaging visualization with AI-driven automations, enhancing clinician diagnostic precision and patient care while reducing manual efforts.
• It introduces advanced structural heart imaging simulations in a single solution, including Transcatheter Tricuspid Valve Replacement (TTVR), Transcatheter Mitral Valve Repair (TMVR), and Advanced Left Atrial Appendage (LAA) procedures, along with 3D batching and integrated AI-driven tools
• The solution (also available as SaaS) allows user selected integration with third-party 3D segmentation models, such as NVIDIA NIM^TM, expanding AI capabilities for clinical research.

CAMBRIDGE, Mass.—Nov. 20, 2025—ConcertAI’s TeraRecon, a leading provider of AI-empowered AV clinical workflows, visualization, ​and interoperability solutions, today announced TeraRecon AV^TM, an advanced medical imaging visualization solution that enhances clinician diagnostic precision, streamlines processes, and improves patient care with AI-driven automation and new specialized clinical tools. Its secure, cloud-based infrastructure integrates seamlessly with any existing Radiology or Cardiology Picture Archiving and Communication System (PACS) to create a standardized imaging enterprise that supports diverse needs across sub-specialties.

“We developed TeraRecon AV^TM in collaboration with healthcare and imaging specialists to address their real-world needs, with the primary goals of giving them more time to spend with their patients while enabling faster, more confident diagnoses that lead to earlier treatment,” said Eron Kelly, CEO of ConcertAI. “These needs drove our focus to provide customers with a solution that integrates new AI abilities and automated reporting to deliver the best possible outcomes for patients across healthcare organizations.”

TeraRecon AV^TM introduces advanced capabilities designed to improve clinical decision-making, operational efficiency, and cost-effectiveness. While maintaining existing capabilities of advanced vizualization, it introduces new structural heart simulations, faster image processing, and integrated AI tools for greater efficiency and clinician diagnostic confidence:

• New Transcatheter Tricuspid Valve Replacement (TTVR) Automation: Comprehensive tools for calcium scoring, valve measurements, and leaflet length calculations.
• Enhanced Transcatheter Tricuspid Valve Replacement(TMVR) Process: Semi-automated device placement and septal puncture simulation for improved accuracy.
• Advanced Left Atrial Appendage (LAA) Process: Semi-automated device placement and catheter simulation for surgical planning.
• Zero-Click 3D Batching: Semi-automated 3D rotations, flips, and bone removal for faster image processing.
• Enterprise-Ready Cloud Solution: Scalable, secure, and seamlessly integrated into existing ecosystem.
• Third-Party 3D Segmentation Model Integration: Allows user selected integration of third-party 3D segmentation models, such as NVIDIA NIM^TM, for clinical research.
• Multiple language/localization: Supports 11 languages for global deployment.
• Integrates FDA cleared clinical AI to automate segmentations and streamline surgical planning and image interpretation tasks, such as Centerlines, Calcium Scoring for CT, and Long Axis for Cardiac MR.

Ultimately, TeraRecon AV^TM delivers value by enabling healthcare organizations to provide quality care, optimize resources, and stay competitive in a rapidly evolving industry:

• Enhanced Patient Care: Improved clinician diagnostic precision and integrated AI-driven insights enable faster, more accurate decisions, leading to better patient outcomes and confidence in treatment planning.
• Operational Efficiency: Streamlined processes, automation, and reduced manual effort allow healthcare teams to handle more cases with fewer resources.
• Cost Savings: Consolidating imaging needs into a single, scalable solution reduces the need for multiple niche solutions, lowering overall costs.
• Scalability and Flexibility: The secure, cloud-based infrastructure adapts to growing demands, ensuring long-term value and seamless integration into existing systems.
  

About ConcertAI: ConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai™ technologies and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers and medical societies. TeraRecon provides AV, AI and image viewing solutions for medical imaging, including 3D post-processing tools used in radiology, cardiology, neurology and oncology. CancerlinQ® is an initiative of ConcertAI, providing oncology providers with ASCO­aligned automated QOPI and ASCO Certified® quality solutions and SmartlinQ™ analytic services. Headquartered in Cambridge, Mass., ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham and Tokyo. For more information, visit us at concertai.com.

Media Contact
Treble
Jim Cameron
concertai@treblepr.com

 Q&A: ConcertAI Establishes the New Standard of Medical AI Imaging with TeraRecon AV^TM 

Q: What is TeraRecon AV^TM?

TeraRecon AV^TM is a leading advanced medical imaging visualization solution that enhances clinician diagnostic precision, streamlines processes, and enhances patient care with AI-driven automation and specialized clinical tools. Its secure, cloud-based infrastructure integrates seamlessly with any existing PACS system to create a standardized enterprise environment that supports diverse imaging needs across specialties. TeraRecon AV^TM, our most recent advanced visualization solution, delivers advanced structural heart automations, 3D batching, and integrated AI tools for greater efficiency and clinician diagnostic confidence. 

Q: What’s new in TeraRecon AV^TM?

TeraRecon AV^TM adds structural heart imaging automation designed to support faster, more accurate clinician decision-making and diagnosis. With advanced simulations, streamlined automations, and specialized processes for TTVR, TMVR, and LAA procedures, it provides clinicians with essential tools for calcium scoring, valve measurements, and catheter placement simulation. Zero-click 3D batching reduces manual effort, while consistent and reliable measurements enhance clinician diagnostic confidence. Developed in collaboration with clinicians to address real-world needs, this enterprise-ready cloud platform integrates seamlessly into existing systems, improving efficiency, accuracy, and planning. Additionally, import of measurements from third-party 3D segmentation models from companies such as NVIDIA is now possible in the product’s SaaS version.

Q: What’s the value proposition for healthcare organizations to invest in TeraRecon AV^TM?

TeraRecon AV^TM delivers value by enabling healthcare organizations to provide quality care, optimize resources, and stay competitive in a rapidly evolving industry. That includes:

• Enhanced Patient Care: Improved clinician diagnostic precision and integrated AI-driven insights enable faster, more accurate decisions, leading to better patient outcomes and confidence in treatment planning.
• Operational Efficiency: Streamlined processes, automation, and reduced manual effort allow healthcare teams to handle more cases with fewer resources.
• Cost Savings: Consolidating imaging needs into a single, scalable platform reduces the need for multiple niche solutions, lowering overall costs.
• Scalability and Flexibility: The secure, cloud-based infrastructure adapts to growing demands, ensuring long-term value and seamless integration into existing systems.
• Vendor agnostic: TeraRecon AV^TM works with all PACS and imaging vendors to provide a common platform with the most advanced capabilities.

*TeraRecon AV is a medical device registered as Intuition in worldwide markets